At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 50 enrolled

Drug / intervention

CCK +1 morebiological

Likely dose

CCK 0.02mg/kgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02748525

NCT02748525Phase 4Completed

Compare CT.gov

Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively

The University of Texas Health Science Center, Houston·interventional·Posted Apr 22, 2016·Updated Jul 2, 2019

In Brief

A Phase 4 clinical trial evaluating Milk and CCK for Abdominal Pain. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAbdominal Pain

CountriesUnited States

Collaborators--

Timeline

Phase 4CompletedFinished

2017201820192020202120222023202420252026

First PostedApr 2016

Enrollment StartMay 2016

Primary CompletionJun 2018

TodayJul 2026

First PostedApr 22, 2016

Enrollment StartMay 3, 2016

Primary CompletionJun 14, 2018

TodayJul 2, 2026

Enrollment to primary: 2.1 yearsPosted 10.2 years ago

Interventions

Milkother

Milk, in the form of 8 oz. half and half, administered after CCK scan, and patient is rescanned and ejection fraction measured to determine if ejection fraction is low.

CCKbiological

CCK is standard of care, used in HIDA scans for gallbladder function evaluation. It is given intravenously to cause the gallbladder to contract. The usual dose of CCK is 0.02mg/kg slowly over 3 minutes as per standard.